Sjogren Syndrome Clinical Trials

6 recruiting

Sjogren Syndrome Trials at a Glance

9 actively recruiting trials for sjogren syndrome are listed on ClinicalTrialsFinder across 6 cities in 8 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Baltimore, Beijing, and Beijing. Lead sponsors running sjogren syndrome studies include Centre Hospitalier Universitaire de Saint Etienne, National Cancer Institute (NCI), and Center For Sight.

Browse sjogren syndrome trials by phase

Treatments under study

About Sjogren Syndrome Clinical Trials

Looking for clinical trials for Sjogren Syndrome? There are currently 6 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Sjogren Syndrome trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Sjogren Syndrome clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Phase 1

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Malignant Solid NeoplasmHematopoietic and Lymphoid Cell NeoplasmRheumatoid Arthritis+11 more
National Cancer Institute (NCI)300 enrolled52 locationsNCT03816345
Recruiting
Not Applicable

Fatigue in Sjögren's Syndrome: 3 Therapeutic Strategies

Sjogren Syndrome
Centre Hospitalier Universitaire de Saint Etienne174 enrolled1 locationNCT06875102
Recruiting
Phase 4

TREATMENT OF VAGINAL DRYNESS IN SJÖGREN'S DISEASE WITH CO2-LASER VERSUS TOPICAL PROMESTRIENE

Sjogren SyndromeSjogren DiseasePrimary Sjogren Syndrome
University of Sao Paulo General Hospital60 enrolled1 locationNCT07153276
Recruiting
Phase 4

Evaluating a New Therapy for Dry Eye in Patients With Sjögren's Syndrome

Sjogren Syndrome With Keratoconjunctivitis
Center For Sight35 enrolled1 locationNCT07277257
Recruiting
Phase 1Phase 2

Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune Diseases

Sjogren SyndromeSystemic Lupus ErthematosusSystemic Sclerosis (SSc)+3 more
Peking University Third Hospital9 enrolled1 locationNCT06828042
Recruiting

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+188 more
Sanford Health20,000 enrolled2 locationsNCT01793168
Recruiting
Phase 2

BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases

Systemic Lupus ErythematosusSjogren SyndromeInflammatory Myopathy+6 more
Peking University People's Hospital50 enrolled1 locationNCT06794008
Recruiting
Not Applicable

Home Based Clinical Management of Interstitial Lung Disease in Systemic Rheumatic Diseases

Rheumatoid ArthritisConnective Tissue DiseasesDermatomyositis+3 more
Oslo University Hospital218 enrolled1 locationNCT06732674
Recruiting

Rare AutoImmune SElf-management Programme Development

Sjogren SyndromeSystemic Lupus ErthematosusSystemic Sclerosis (SSc)+3 more
University of the West of England360 enrolled1 locationNCT06642870